36 / 148
36
Informaciones
Psiquiátricas
2018 - n.º
232
Bibliografía
1. Valls-Pedret C, Molinuevo JL, Rami L.
Diagnóstico precoz de la enfermedad de
Alzheimer: fase prodrómica y preclíni-
ca. Rev Neurol 2010; 51: 471-80.
2. Dubois B. ‘Prodromal Alzheimer’s disea-
se’: a more useful concept than mild
cognitive impairment? Curr Opi Neurol
2000; 13: 367-9.
3. Sperling RA, Aisen PS, Beckett LA, Da-
vid A, Craft S, Fagan AM, Iwatsubo T,
Clifford R. Kaye JJ, Montine TJ, Park D,
Reiman EM, Rowe C, Siemers E, Stern
Y, Yaffe K, Carrillo M, Thies B, Morri-
son-Bogorad M, Wagster M, Phelps C
(2011) Toward defining the preclinical
stages of Alzheimer’s disease: recom-
mendations from the National Insti-
tute on Aging-Alzheimer’s Association
workgroups on diagnostic guidelines
for Alzheimer’s disease. Alzheimer’s &
Dementia; 7: 280-292.
4. Zack CR, Knopman DS, Weigand SD,
Wiste HJ, Vemuri P, Lowe V, Kantar-
ci K, Gunter JL, Senjem ML, Ivnik RJ,
Roberts RO, Rocca WA, Boeve BF and
Petersen RC. (2012), An operatio-
nal approach to National Institute on
Aging–Alzheimer's Association criteria
for preclinical Alzheimer disease. Ann
Neurol., 71: 765-775.
5. Cejudo JC, Gil D. Redefining mild cog-
nitive impairment (a-MCI) as an early
form of Alzheimer’s disease based on
assessment of memory systems. J Al-
zheimers Dis. 2016;53(2):705-12.
Juan Carlos Cejudo